FINRA focus on “worst-of” structured notes: Heightened scrutiny of concentrations and Reg BI compliance
May 21, 2026
FINRA focus on “worst-of” structured notes: Heightened scrutiny of concentrations and Reg BI complianceMay 21, 2026 On May 19, 2026, FINRA announced a targeted review of member firms’ practices relating to the supervision of non-principal-protected “worst-of” structured notes, which it has identified as higher-risk structured products. The initiative reflects FINRA’s continued focus on firms’ obligations under Regulation Best Interest (Reg BI). For member firms with structured products activity, we expect this initiative to result in targeted sweeps and exam prioritization of this topic within both existing FINRA reviews and examinations and those yet to be commenced. Scope of FINRA’s Review Per its sweep letter, FINRA’s review will cover the period of January 1, 2022 through December 31, 2025. The review will focus on how firms supervise customer concentrations in higher-risk structured notes, particularly those with worst-of features and no principal protection. The inquiry centers on firms’ compliance with Reg BI, including the Care Obligation, encompassing both reasonable-basis and customer-specific suitability determinations, and the Conflict of Interest Obligation, particularly the identification and mitigation of incentives associated with product recommendations. FINRA is also assessing compliance with applicable supervisory rules, with a focus on the adequacy and effectiveness of written supervisory procedures (WSPs) and surveillance systems. Key Areas of Regulatory Focus Based on FINRA’s enumerated information requests, firms should expect scrutiny across several core areas of their structured products frameworks:
Focus on Firms’ Actual Practices FINRA’s review is expected to extend beyond firms’ written policies and focus closely on how those policies operate in practice. In particular, FINRA is likely to assess whether firms are actively monitoring and enforcing concentration limits, maintaining adequate documentation to support Reg BI determinations, and ensuring alignment between product risk, customer profiles, and recommendations. FINRA is also expected to examine the effectiveness and timeliness of supervisory responses to alerts, as well as whether compensation structures create incentives that are appropriately identified and mitigated. Implications for Firms Consistent with our observations in representing broker-dealers in FINRA investigations involving recommendations and supervision of structured products, including under Reg BI, this initiative underscores FINRA’s continued concern with the risks associated with complex products and the heightened expectations for supervision under Reg BI. Firms that permit recommendations of non-principal-protected structured notes, particularly those with worst-of features, should expect increased regulatory scrutiny. In our experience, areas of potential regulatory exposure often include:
Taken together, these issues reflect recurring themes in regulatory inquiries: a disconnect between policy and practice, insufficient focus on product risk in the context of the customer profile, and inadequate supervisory oversight and documentation. Recommended Next Steps Firms may consider conducting a proactive review of their structured products frameworks. This includes reviewing and, where appropriate, enhancing written supervisory procedures and product classification methodologies, as well as assessing current product due diligence protocols. Firms can consider evaluating the adequacy of concentration limits and related supervisory controls, along with the effectiveness of surveillance systems, exception reports, and escalation practices. In addition, firms can test the robustness of documentation supporting Reg BI compliance, review compensation practices and related conflict mitigation measures, and assess the sufficiency of training programs and customer-facing disclosures. Proactive review can help identify and address potential issues early and position firms effectively in the event of a FINRA sweep or examination. For additional information or to discuss how this development may affect your firm, please contact any member of our team. __________ If you have any questions about this Legal Briefing, please feel free to contact any of the attorneys listed or the Eversheds Sutherland attorney with whom you regularly work. Latest Insights
Latest News
Latest Events
legal updates November 20, 2026 COP31: Enhancing Implementation - Revised draft seeks consensus amid compet... legal updates November 20, 2026 Implementation of the EU Pay Transparency Directive: New development in Spa... legal updates November 20, 2026 CDTFA issues updated proposed emergency regulations on California’s imminen... legal updates November 19, 2026 BIS closes the remote-access gap with interim final rule client news November 19, 2026 Eversheds Sutherland advises EDF on landmark UK energy retail acquisition firm news November 19, 2026 Eversheds Sutherland’s Aileen Crowson Elected to Lead the Association of Pr... media mentions November 17, 2026 Trump moves to ease pension rules for investment firms linked to misconduct client news November 17, 2026 Eversheds Sutherland Advises Vireo Growth Inc. on Acquisition of FLUENT Cor... hybrid Europe Action Week 2026 Europe Action Week returns this November with a dynamic mix of events designed to help you navigate what’s next. virtual Immigration UK Business – sponsor licencing course November 24, 2026 9.30am - 11.30am (GMT) Virtual virtual UK employment law training December 01, 2026 1pm - 4pm (GMT) Virtual virtual Strategic Reflections on COP31 December 02, 2026 10am GMT | 11am CET Virtual, |